3 x 14 mg/m2 Idarubicin during induction:: results of a pilot study in children with AML

被引:9
作者
Creutzig, U [1 ]
Körholz, D [1 ]
Niemeyer, CM [1 ]
Kabisch, K [1 ]
Graf, N [1 ]
Reiter, A [1 ]
Scheel-Walter, H [1 ]
Bender-Götze, C [1 ]
Behnisch, W [1 ]
Hermann, J [1 ]
Mann, G [1 ]
Ritter, J [1 ]
Zimmermann, M [1 ]
机构
[1] Klin & Poliklin Kinderheilkunde, D-48129 Munster, Germany
关键词
D O I
10.1038/sj.leu.2401670
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:340 / 342
页数:3
相关论文
共 5 条
[1]  
Berman E, 1993, Oncology (Williston Park), V7, P91
[2]   Definition of a standard-risk group in children with AML [J].
Creutzig, U ;
Zimmerman, M ;
Ritter, J ;
Henze, G ;
Graf, N ;
Löffler, H ;
Schellong, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (03) :630-639
[3]  
CREUTZIG U, 1999, IN PRESS ACUTE LEUKE, V7
[4]  
DAGHESTANI AN, 1985, CANCER RES, V45, P1408
[5]  
WIERNIK PH, 1992, BLOOD, V79, P313